Podlekareva et al reported a Health Care Index (HCI) score to predict the mortality rate for a patient infected with both HIV and tuberculosis. This can help to determine if a patient is getting appropriate health care. The authors are from multiple universities in Europe and Argentina participating in the HIV-TB Study Group.
Patient selection: HIV patient diagnosed with tuberculosis
Parameters:
(1) drug susceptibility testing (DST)
(2) initial tuberculosis treatment
(3) combination antiretroviral therapy
Parameter |
Finding |
Points |
drug susceptibility testing |
not performed |
0 |
|
performed |
1 |
initial TB therapy |
with isoniazid, pyrazinamide and rifamycin |
2 |
|
other |
0 |
antiretroviral therapy |
started before or up to 1 month after TB diagnosed |
2 |
|
not started or started more than a month after TB diagnosed |
0 |
where:
• Drug susceptibility testing implies a culture isolate which means that a definitive diagnosis is made. It also means that the patient’s therapy is likely to be adjusted for any resistance identified.
total HCI score =
= SUM(points for all 3 parameters)
Interpretation:
• minimum score: 0
• maximum score: 5
• The higher the score the better the survival.
HCI Score |
1 Year Mortality Rate |
0 |
39% |
1 |
32% |
2 |
21% |
3 |
15% |
4 or 5 |
9% |
Specialty: Infectious Diseases, Pulmonology
ICD-10: ,